High Donor and Recipient Age Are Not Risk Factors for Chronic Graft-Versus-Host Disease in the Setting of Anti-Thymocyte Globulin-Conditioned Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Lim, Andrew Boon Ming [1 ]
Storek, Jan [2 ]
Beligaswatte, Ashanka [3 ]
Collins, Marnie [4 ]
Mason, Kate [5 ]
Li, Emily Peizhen [5 ]
Chaudhry, Ahsan [6 ]
Russell, James A. [2 ]
Daly, Andrew [2 ]
Szer, Jeffrey [7 ]
Lewis, Ian [8 ]
Ritchie, David Stuart [1 ,9 ]
机构：
[1] Royal Melbourne Hosp, Clin Haematol & Bone Marrow Transplant Serv, Parkville, Vic 3050, Australia
[2] Foothills Prov Gen Hosp, Tom Baker Canc Ctr, Blood & Bone Marrow Transplant Program, Calgary, AB T2N 2T9, Canada
[3] Royal Adelaide Hosp, Dept Haematol, Adelaide, SA 5000, Australia
[4] Ctr Biostat & Clin Trials, Melbourne, Australia
[5] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[6] Alberta Blood & Marrow Transplant Program, Calgary, AB, Canada
[7] Royal Melbourne Hosp, Clin Haematol & BMT Serv, Parkville, Vic 3050, Australia
[8] Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[9] Peter MacCallum Canc Ctr, Melbourne, Australia
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2013年 / 19卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
450
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 50 条
  • [1] Incomplete chimerism following myeloablative and anti-thymocyte globulin-conditioned hematopoietic cell transplantation is a risk factor for relapse and chronic graft-versus-host disease
    Khanolkar, Rutvij A.
    Tripathi, Gaurav
    Dharmani-Khan, Poonam
    Dabas, Rosy
    Kinzel, Megan
    Kalra, Amit
    Puckrin, Robert
    Jimenez-Zepeda, Victor
    Jamani, Kareem
    Duggan, Peter R.
    Chaudhry, Ahsan
    Bryant, Adam
    Stewart, Douglas A.
    Khan, Faisal M.
    Storek, Jan
    [J]. CYTOTHERAPY, 2022, 24 (12) : 1225 - 1231
  • [2] Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation
    Bosch, Mark
    Dhadda, Manveer
    Hoegh-Petersen, Mette
    Liu, Yiping
    Hagel, Laura M.
    Podgorny, Peter
    Ugarte-Torres, Alejandra
    Khan, Faisal M.
    Luider, Joanne
    Auer-Grzesiak, Iwona
    Mansoor, Adnan
    Russell, James A.
    Daly, Andrew
    Stewart, Douglas A.
    Maloney, David
    Boeckh, Michael
    Storek, Jan
    [J]. CYTOTHERAPY, 2012, 14 (10) : 1258 - 1275
  • [3] Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia
    Lv, Meng
    Zhang, Xiaohui
    Xu, Lanping
    Wang, Yu
    Yan, Chenhua
    Chen, Huan
    Chen, Yuhong
    Han, Wei
    Wang, Fengrong
    Wang, Jingzhi
    Liu, Kaiyan
    Huang, Xiaojun
    Mo, Xiaodong
    [J]. FRONTIERS OF MEDICINE, 2019, 13 (06) : 667 - 679
  • [4] Risk factors for chronic graft-versus-host disease after anti-thymocyte globulin-based haploidentical hematopoietic stem cell transplantation in acute myeloid leukemia
    Meng Lv
    Xiaohui Zhang
    Lanping Xu
    Yu Wang
    Chenhua Yan
    Huan Chen
    Yuhong Chen
    Wei Han
    Fengrong Wang
    Jingzhi Wang
    Kaiyan Liu
    Xiaojun Huang
    Xiaodong Mo
    [J]. Frontiers of Medicine, 2019, 13 : 667 - 679
  • [5] Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation
    Al-Kadhimi, Zaid
    Gul, Zartash
    Rodriguez, Roberto
    Chen, Wei
    Smith, Daryn
    Mitchell, Alice
    Abidi, Muneer
    Ayash, Lois
    Deol, Abhinav
    Lum, Lawrence
    Forman, Stephen
    Ratanatharathorn, Voravit
    Uberti, Joseph
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (11) : 1734 - 1744
  • [6] Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia
    Hu, Mengze
    Li, Junhui
    Hu, Tao
    Zhang, Zhaoxia
    Feng, Shunqiao
    Xuan, Litian
    Liu, Rong
    [J]. LEUKEMIA & LYMPHOMA, 2024,
  • [7] Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin
    Remberger, M
    Aschan, J
    Barkholt, L
    Tollemar, J
    Ringdén, O
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 (03) : 147 - 153
  • [8] Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
    Osamu Imataki
    Kensuke Matsumoto
    Makiko Uemura
    [J]. Journal of Cancer Research and Clinical Oncology, 2017, 143 : 709 - 715
  • [9] Low-dose anti-thymocyte globulin reduce severe acute and chronic graft-versus-host disease after allogeneic stem cell transplantation
    Imataki, Osamu
    Matsumoto, Kensuke
    Uemura, Makiko
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (04) : 709 - 715
  • [10] Association between the pharmacokinetics of rabbit anti-thymocyte globulin and acute graft-versus-host disease in patients who received haploidentical hematopoietic stem cell transplantation
    Masahiro Teramoto
    Satoshi Maruyama
    Hiroya Tamaki
    Katsuji Kaida
    Azusa Mayumi
    Keiko Fukunaga
    Takayuki Inoue
    Kyoko Yoshihara
    Satoshi Yoshihara
    Kazuhiro Ikegame
    Masaya Okada
    Yuko Osugi
    Hiroyasu Ogawa
    Satoshi Higasa
    Kunihiko Morita
    Kana Matsumoto
    Takashi Kijima
    [J]. International Journal of Hematology, 2022, 116 : 248 - 257
12345